Noida ADM reviews plantation drive preparations
Noida: ADM (finance and revenue) Atul Kumar held a review meeting at the Collectorate Friday to ensure the success of the upcoming tree plantation campaign. Kumar instructed officials of all departments concerned to provide the forest department with action plans, site identifications, and pit-digging information in a prescribed format for meeting plantation targets.
All SDMs were instructed to virtually select sites along the Hindon and near ponds for the plantation campaign and to send progress reports to the forest department. He also instructed the Authority officials to take effective measures to control air pollution and strictly follow the guidelines of the NGT and Pollution Control Board.
Follow more information on
Air India plane crash in Ahmedabad here
. Get
real-time live updates
on rescue operations and check
full list of passengers onboard AI 171
.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
3 hours ago
- News18
UP's Much-Awaited Pharma Park All Set To Become A Reality By 2027
Last Updated: With construction underway on over 350 acres in the first phase, the project is expected to catalyse investments worth over Rs 12,000 crore Uttar Pradesh's much-awaited Pharma Park is all set to become a reality by 2027 as the state government begins work on North India's first bulk drug and formulation hub in Lalitpur. With construction underway on over 350 acres in the first phase, the project is expected to catalyse investments worth over Rs 12,000 crore and boost UP's bid to become a national pharmaceutical manufacturing powerhouse. Spearheaded by the Uttar Pradesh State Industrial Development Authority (UPSIDA), the Lalitpur Bulk Drug Pharma Park is part of UP government's move to make the state self-reliant in bulk drug and Active Pharmaceutical Ingredient (API) production, while transforming Bundelkhand into an industrial powerhouse. Spread over 1,472 acres, the park is being developed in phases. Construction work for the first phase, covering 353 acres, is already underway. According to UPSIDA, environmental clearances have been secured, and land allotment to industries has begun. UPSIDA regional manager Sandeep Kumar confirmed that four pharmaceutical companies have submitted applications to set up units within the park. Of these, IJ Pharma and Badariya Pharma have already been allotted plots, while Riddhi Siddhi Pharma and JBJM Pharmaceuticals are in the final stages of the allotment process. 'Contracts with two companies are complete, while documentation for the remaining two is ongoing," Kumar said. The project has already caught the attention of prominent investors. During a recent investment roadshow in Ahmedabad, several pharma companies signed key proposals. UPSIDA CEO Mayur Maheshwari stated that the authority will conduct similar outreach initiatives in Mumbai, Chandigarh, and Hyderabad to attract more pharma players. Maheshwari described the park as a 'state-of-the-art plug-and-play facility" tailored to meet global standards. 'All utilities—electricity, water, waste management—are being designed for 24/7 industrial support. The entire park will be based on Zero Liquid Discharge (ZLD), ensuring that no untreated wastewater leaves the premises," he said. The park's underground utility network will include steam and solvent recovery systems, climate-controlled warehouses, and dedicated logistics corridors. A waste management system with a 3.53 TPD capacity, 33/11 KV sub-stations, and a 75 TPH steam distribution system will be in place to ensure operational efficiency. Safety and support infrastructure are also in focus. Plans include CCTV surveillance, boundary fencing, emergency service centers, and in-house skilling centres for local manpower training. Affordable housing for workers and executives is also under development within the premises. Investor Incentives UPSIDA has rolled out a special industrial land allotment scheme for the pharma park. Plots are priced at Rs 1,914 per square meter, with an additional 2 per cent discount for one-time payment. These rates, according to UPSIDA officials, are highly competitive compared to other pharma hubs in India and are expected to attract significant interest from small and mid-sized pharmaceutical players. 'Infrastructure, regulatory clearances, and affordability are all aligned to offer investors a compelling alternative to Gujarat or Hyderabad," said Maheshwari. The Lalitpur Pharma Park has already begun attracting significant industrial investments. CSL Life Sciences Pvt Ltd has proposed a Rs 200 crore investment to set up two manufacturing units—an IV Bottle Plant and an Oral Solid Dosage (OSD) Plant—spread over 5 to 7 acres. These units are expected to generate employment for over 250 people and become operational within the next two years. In addition, Mediheath Diagnostic Pvt Ltd is establishing a healthcare and diagnostic unit on a 4,200-square-meter plot, while Gaman Irradiation has announced plans to invest Rs 35 crore in a skin treatment and irradiation facility that is projected to create around 150 jobs within 24 to 36 months. Another major entrant, Obmed Pharma, has committed Rs 200 crore for setting up a formulation unit on a five-acre plot, which is expected to employ approximately 100 workers. These early investments signal strong industry confidence in the project and are expected to accelerate momentum as the park gains visibility on the national pharmaceutical landscape. Strong Connectivity The Lalitpur pharma park benefits from excellent multi-modal connectivity. The site is linked via MDR 35B, with NH-44 and NH-539 nearby, and is connected by rail through Tikamgarh and Lalitpur Junction. Air connectivity is facilitated via Khajuraho Airport (125 km away) and Lucknow Airport (385 km away). The proximity to the Jhansi node of the Uttar Pradesh Defence Corridor adds strategic value, as does its alignment with the state's broader goal of becoming a $1 trillion economy. According to Maheshwari, the Lalitpur pharma park is being developed in collaboration with leading national institutions like IIT, DRDO, and private consultancy firm Assystem India Limited, which has experience working on world-class pharma parks in Visakhapatnam. top videos View all 'We're not just matching global standards — we're aiming to surpass them," he said. 'Uttar Pradesh is well-positioned to fill the gap left after tax benefits in Himachal Pradesh ended. With the right policies, infrastructure, and investor confidence, we're ready to take the lead in pharma manufacturing." With construction in full swing, the park is expected to show physical results within two years, potentially transforming Lalitpur into India's premier bulk drug manufacturing hub. First Published: News india UP's Much-Awaited Pharma Park All Set To Become A Reality By 2027
Time of India
13 hours ago
- Time of India
Which stocks should traders buy as indices hit a nine-month high?
As benchmark indices hit a nine-month high in the last week of June, traders are looking to ride the bullish wave. A look at some of the stock futures that have seen higher-than-average rollovers to the July series and poised to move up further. HPCL CMP: Rs 439 Change in Open Interest in July Series: 9% Change in Price in July Series: 4.3% Decline in crude oil prices has supported oil marketing companies move higher, said Chandan Taparia, head of technical and derivatives research at Motilal Oswal Financial Services . 'The stock has seen meaningful long additions on Friday and has been making higher lows for the last 4 trading sessions,' he said. The stock also gave a consolidation breakout after 35 long weeks. Traders can buy the contracts with support at Rs 425 for an upside target towards Rs 465 levels. ULTRATECH CEMENT CMP: Rs 12,234 Change in Open Interest in July Series: -2.81% Change in Price in July Series: +1.96% Live Events The stock rose due to short covering on Friday, said Vipin Kumar, AVP, derivatives and technical research at Globe Capital Market. 'On charts, it is trading on the verge of a fresh breakout from a year-long congestion zone at Rs 10,130-12,396. Considering its current chart structure and derivatives data, we expect the stock to move northward in near term and test Rs 13,500- Rs 14,000 levels,' he said. Kumar suggested traders buy its July futures with a stop loss at Rs 11,400. POWER GRID CORP CMP: `299 Change in Open Interest in July Series: -1% Change in Price in July Series: +1.60% Technically, it is well placed on multiple time frames and has bounced back sharply from its price support of `285, said Kumar. 'All the parameters are indicating higher probability of positive momentum in this stock in the near term,' he said. Hence, we suggest traders to go long till it is holding above `284 levels and expect it to test `315-`325 in near term.' INDRAPRASTHA GAS CMP: Rs 213.85 Change in Open Interest in July Series: 13% Change in Price in July Series: 3% Indraprastha has given a consolidation breakout on daily and weekly charts with a decisive close above Rs 214 levels, said Taparia. 'The stock has seen support-based buying with addition in option interests, which clearly indicates that longs are being added at current juncture for next move,' he said. Traders can buy Indraprastha contracts with support at Rs 207 for an upside target towards Rs 228. APOLLO HOSPITALS CMP: Rs 7,305 Change in Open Interest in July Series: 0.38% Change in Price in July Series: 2.71% Sudeep Shah, head, technical and derivative research at SBI Securities, said, on daily chart, stock has registered a breakout supported by robust volume participation— signalling strong buying interest. 'This breakout not only validates the underlying strength but also marks shift in sentiment after consolidation,' he said. Shah recommends stock in the zone of Rs 7,320-Rs 7,280 with a stop loss of Rs 7,080, for a target of Rs 7,750. HDFC LIFE INSURANCE CMP: Rs 807.35 Change in Open Interest in July Series: -6.28% Change in Price in July Series: 0.34% Shah said the stock has recently given a 'stage-2 cup pattern' breakout on a daily scale. 'This breakout is confirmed by robust volume. Currently, the stock is trading above its short and longterm moving averages, and these averages are edging higher, which is a bullish sign,' he said. He recommends accumulating the stock in the zone of `810-`800 with a stop loss of `780, for a target of `870 in the short term.
Time of India
18 hours ago
- Time of India
Allahabad HC quashes Greater Noida order to cancel plots, cites possession delay and lack of civic infra
Noida: In a legal setback to Greater Noida Industrial Development Authority (GNIDA), Allahabad high court has quashed two separate plot cancellation orders, saying the Authority "failed to meet deadlines and followed flawed processes". One order was related to a large IT/ITES project in Tech Zone II and the other to a group housing project in Sector 10. The twin verdicts, delivered earlier this month by Justice Prakash Padia, restored the allotments and brought relief to the realtors, Elevator Properties and Kinetic Buildtech. They had challenged GNIDA's actions in court, alleging that its own defaults stalled their projects. You Can Also Check: Noida AQI | Weather in Noida | Bank Holidays in Noida | Public Holidays in Noida In the first case, on June 16, 2023, GNIDA had cancelled the allotment, citing non-utilisation of land, non-obtaining of a completion certificate and failure to deposit due payments. The 25-acre IT/ITES plot was originally allotted in Oct 2007 to a consortium led by Anant Raj Industries Ltd. It was later transferred to its subsidiary, Elevator Properties, through a lease deed in Aug 2010. Despite over a decade passing, no construction took place. Against the cancellation, Elevator Properties filed a petition in the HC in 2024, arguing that the Authority failed to complete external development works, such as roads, drainage and services, making the land commercially unusable, despite the developer paying the entire premium at lease execution. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 5 Books Warren Buffett Wants You to Read In 2025 Blinkist: Warren Buffett's Reading List Undo A key legal issue was the amendment to Section 7 of the Uttar Pradesh Industrial Area Development Act in 2022, allowing the Authority to cancel non-utilised plots only by first issuing notice at least three months before Dec 31, 2022, directing the allottee to complete construction by that date. If the plot remained unused, it would stand automatically cancelled on Dec 31, 2022. GNIDA, however, issued its notice only on Jan 3, 2023, after the cut-off date of Sept 30, 2022 to issue such notices. In his order, Justice Prakash Padia ruled that after missing the statutory deadline, GNIDA lost legal power to cancel under this amended provision. The court called the cancellation "wholly without jurisdiction" and "perverse," restoring the allotment and entitling Elevator Properties to consequential benefits. The court also noted GNIDA's cancellation had earlier been upheld by an order dated Nov 23, 2023, passed by the principal secretary, industrial development department, which the court has now set aside. In the second case, the court quashed GNIDA's 2017 cancellation of a plot measuring five acres, allotted to Kinetic Buildtech in May 2014 under a group housing scheme. The plot was allotted in 2014 and the petition against the cancellation was filed in this case in May 2023.
